The 3rd COPENHAGEN Puberty Study
NCT04884620 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 3000
Last updated 2024-01-10
Summary
The COPENHAGEN School Study is a combined cross-sectional and longitudinal study of healthy Danish school children. This study will by clinical examinations and withdrawal of blood samples investigate whether age of pubertal onset is continuing to decline in Denmark over the past 15 years. Furthermore, we will investigate the mechanism driving earlier onset of puberty and the long term health risks of extremely early puberty using Danish registry data
Conditions
- Puberty
- Puberty, Precocious
Sponsors & Collaborators
-
Environmental Protection Agency (EPA)
collaborator FED - collaborator OTHER
-
Rigshospitalet, Denmark
lead OTHER
Principal Investigators
-
Anders Juul, PhD, DMSc · Rigshospitalet, Department of Growth and Reproduction
Eligibility
- Min Age
- 5 Years
- Max Age
- 19 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2023-01-01
- Primary Completion
- 2026-12-31
- Completion
- 2056-12-31
Countries
- Denmark
Study Locations
More Related Trials
-
Post-marketing Evaluation of Reactions Following Receipt of Recommended Adolescent Pertussis Vaccine
NCT00304265 ·Status: COMPLETED ·Phase: PHASE4
-
COVID-19 Booster Dose Reminder/Recall for Adolescents
NCT05571657 ·Status: UNKNOWN ·Phase: NA
-
Evaluation of Vaccination Reminder/Recall Systems for Adolescent Patients
NCT00715234 ·Status: COMPLETED ·Phase: NA
-
Adacel® Booster Vaccination for CMI Assay Development
NCT04543669 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluation of Vaccination Reminder/Recall Systems for Adolescent Patients
NCT01057888 ·Status: COMPLETED ·Phase: NA
-
Study of DTap-IPV Compared to DAPTACEL® and IPOL® as the 5th Dose in Children 4 to 6 Years of Age
NCT01346293 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Immunogenicity in Adults of Revaccination With Adacel® Vaccine 10 Years After a Previous Dose
NCT01439165 ·Status: COMPLETED ·Phase: PHASE4
-
REVAXIS® Versus DT Polio® as a Second Booster in 6 Year-old Children
NCT00447525 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Evaluate the Immune Response After Booster Vaccination With Tdap-IPV Vaccine (Against Tetanus, Diphtheria, Pertussis and Poliomyelitis) in Children Who Received Different Pertussis Primary Vaccine Regimens in Republic of South Africa
NCT04300192 ·Status: COMPLETED ·Phase: PHASE4
-
Immune Responses in Adults to Revaccination With ADACEL® 10 Years After a Previous Dose
NCT00712959 ·Status: COMPLETED ·Phase: PHASE4
-
Study of Adacel® Vaccine Administered to Persons 10 Years of Age
NCT01311557 ·Status: COMPLETED ·Phase: PHASE4
-
Immunogenicity and Safety of the Concomitant Administration of a Tdap Vaccine and Meningococcal ACWY Conjugate Vaccine in Healthy Subjects Aged 11-25 Years
NCT00329901 ·Status: COMPLETED ·Phase: PHASE3
-
The Efficacy of Reminders to Complete HPV Series
NCT01731496 ·Status: COMPLETED ·Phase: NA
-
TDAP Safety in Pregnant Women
NCT02209623 ·Status: COMPLETED
-
Study of Menactra® in US Adolescents When Administered Concomitantly With Tdap Vaccine
NCT00777257 ·Status: COMPLETED ·Phase: PHASE4
-
Adolescent Vaccination Reminder Study
NCT01732315 ·Status: COMPLETED ·Phase: NA
-
Safety and Immunogenicity of Vi-DT Typhoid Conjugate Vaccine in Indonesian Adults, Adolescents, Children and Infants
NCT03460405 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Tetanus and Diphtheria Toxoids Adsorbed Combined With Component Pertussis Vaccine and Inactivated Poliomyelitis
NCT02040636 ·Status: COMPLETED ·Phase: PHASE2
-
Descriptive, Open-label, Multicenter Study of the Safety of Redosing With ADACEL® Vaccine
NCT00347958 ·Status: COMPLETED ·Phase: PHASE4
-
Post-licensure, Modified Double-blind, Multi-center Study Evaluating Safety and Immunogenicity of ADACEL® and BOOSTRIX®
NCT00319553 ·Status: COMPLETED ·Phase: PHASE4
-
Persistence Study of GSK Biologicals' Tdap Vaccine 1, 3, 5 and 9 Years Following Administration as an Initial Single Dose in Healthy Young Adults and to Evaluate the Immunogenicity and Safety of Boostrix as a Second Dose of Tdap, When Administered at Year 9
NCT00489970 ·Status: COMPLETED ·Phase: PHASE3
-
Antitetanus Vaccination for People Older Than 65 Years.
NCT03266211 ·Status: COMPLETED
-
Study of BK1301 (DTaP Vaccine) as a Booster in Adolescents
NCT02118961 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Menactra® in Children Aged 4 to 6 Years When Administered Concomitantly With a Fifth Dose of DAPTACEL®
NCT00355121 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Immunogenicity of Tdap Vaccine Compared to DTaP Vaccine in Children 4 to 6 Years of Age
NCT00467519 ·Status: COMPLETED ·Phase: PHASE3